Filing Flows › ArriVent BioPharma (AVBP) › How it makes money
How ArriVent BioPharma (AVBP) makes money
ArriVent BioPharma (AVBP) made $5.0M of revenue in the third quarter 2026 (Q3 2026).
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $5.0M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $5.0M | — |
From ArriVent BioPharma's 10-Q filed Nov 9, 2026 (on EDGAR).
Questions
How does ArriVent BioPharma make money?
ArriVent BioPharma (AVBP) made $5.0M of revenue in the third quarter 2026 (Q3 2026).
Updated Nov 9, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.